Skip to content

Study to Find Out How Symptoms Severity Changes During the Standard Course of Treatment With the Cream Relief Pro and Suppositories Relief Pro (Active Ingredients Are Fluocortolone + Lidocaine) in Patients Suffering From Twisted and Bulging Veins in the Rectal Area (Acute Hemorrhoids)

Prospective Multicenter Non-interventional Study of Fluocortolone + Lidocaine Formulation in Patients With Acute Hemorrhoids to Evaluate Changes in Symptoms Severity During the Course of Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03757078
Enrollment
1000
Registered
2018-11-28
Start date
2018-11-30
Completion date
2019-10-20
Last updated
2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Hemorrhoids

Brief summary

In this study researcher wanted to learn more about the changes of biggest twisted and bulging veins in the rectal area (hemorrhoids) and changes of symptoms during a treatment period with the cream Relief Pro and suppositories Relief Pro. The study collected information on the treatment satisfaction of patients and their physicians with the prescribed treatment by using questionnaires. There were 3 visits at the physician's clinic for this study: one initial visit and 2 follow-up visits over a period of 2 weeks.

Interventions

DRUGRelief Pro cream

Relief Pro cream:1.0 mg/gm Fluocortolone + 20 mg/gm Lidocaine; Administration according to clinical practice.

DRUGRelief Pro rectal suppositories

Relief Pro rectal suppositories: 1.0 mg Fluocortolone + 40 mg Lidocaine; Administration according to clinical practice

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male & female patients 18 to 65 years old; * Patients with acute hemorrhoids 1 and 2 stage (with thrombosis (external, internal, mixed), including cases with bleeding); * Prescription of fluocortolone + lidocaine as a part of routine clinical practice.

Exclusion criteria

* Patients participating in an investigational program with interventions outside of routine clinical practice; * Hemorrhoid with stage ˃ II; * Contraindications for use of Relief PRO in the approved product label; * Anemia and/or severe/profuse hemorrhoid bleeding; * Surgery in perianal region in anamnesis; * Concomitant treatment with antibiotics/antiseptics, antithrombotics, antineoplastic and/or immunosuppressant; * Inflammatory bowel disease; * Hepatic diseases in severe and acute stages; * Colorectal cancer; * Purulent-inflammatory diseases of the perianal region and anal canal; * Chronic pulmonary diseases in severe and acute stages.

Design outcomes

Primary

MeasureTime frameDescription
Severity of pain (VAS: Visual Analogue Scale)Up to 14 daysPain was measured on a Visual Analogue Scale (VAS) from 0 (No Pain) to 10 (Maximal Pain).
Severity of bleeding (according to 4-point Likert scale)Up to 14 days4-point Likert scale consisting of: 1 (None), 2 (Minimal), 3 (Moderate) and 4 (Significant).
Severity of pruritus (according to 4-point Likert scale)Up to 14 days
Severity of swelling (according to 4-point Likert scale)Up to 14 days
Severity (amount) of discharge (according to 4-point Likert scale)Up to 14 days
Severity of sense of discomfort (according to 4-point Likert scale)Up to 14 days
Overall patient satisfaction with treatment (according to 5-point Likert scale)Up to 14 daysLikert scale: 1 (Very satisfied), 2 (Satisfied), 3 (Neither satisfied nor dissatisfied), 4 (Dissatisfied) and 5 (Very dissatisfied).
Time to onset of analgesic effect after the first use of the drugUp to 14 days
Duration of analgesic effect after the first use of the drugUp to 14 days
Patient's adherence to recommendations of the Investigator by PROUp to 14 daysPRO: Patient Reported Outcome
Information obtained in the course of questioning about the consumer properties of the study product by PROUp to 14 days
Severity of hemorrhoids symptoms according to the Sodergren scoreUp to 14 daysStandardized answer options are given (4 and 5 Likert boxes) and each question gets a score from 0 to 4.
Size of the largest hemorrhoid node measured during a routine examinationUp to 14 days
Severity of swelling when assessed as part of routine examination (according to 4-point Likert scale)Up to 14 days
Severity of bleeding when assessed as part of routine examination (according to 4-point Likert scale)Up to 14 days
Amount of ReliefPro used based on information provided by the patient to the InvestigatorUp to 14 days
Overall satisfaction of Investigator with treatment with Relief Pro according Likert scale from 1 to 5 points as measured on Visits 2 and 3Up to 14 days

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026